These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input. Wagner JG, Szpunar GJ, Ferry JJ. Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396 [Abstract] [Full Text] [Related]
3. Incidence of apparent Michaelis-Menten kinetic behavior of theophylline and its parameters (Vmax and Km) among asthmatic children and adults. Ishizaki T, Kubo M. Ther Drug Monit; 1987; 9(1):11-20. PubMed ID: 3576655 [Abstract] [Full Text] [Related]
16. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine. Woodcock BG, Menke G, Fischer A, Köhne H, Rietbrock N. Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321 [Abstract] [Full Text] [Related]
17. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels. Steinijans VW, Zech K, Fischer R. Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100 [Abstract] [Full Text] [Related]
19. New method for bioavailability assessment of slow-release preparations of theophylline. Kasuya Y, Ohno T, Kubota N, Takahashi H, Hirayama H. J Pharmacokinet Biopharm; 1985 Dec; 13(6):571-87. PubMed ID: 3834072 [Abstract] [Full Text] [Related]
20. Estimation of theophylline absorption rate by means of the Wagner-Nelson equation. Wagner JG. J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):681-8. PubMed ID: 3771958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]